Mesoblast Ltd. (MESO)
Mesoblast Market Cap: 2.386B for Dec. 30, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Telix Pharmaceuticals Ltd. | 2.594B |
| Alterity Therapeutics Ltd. | 56.55M |
| Kazia Therapeutics Ltd. | 10.69M |
| Immutep Ltd. | 420.67M |
| Propanc Biopharma, Inc. | 7.569M |
Market Cap Related Metrics
| PS Ratio | 130.89 |
| Price to Book Value | 4.755 |
| Price | 18.65 |
| Earnings Yield | -4.54% |